![Shorter moxifloxacin-containing regimens ineffective for treating TB [REMoxTB trial]](https://www.2minutemedicine.com/wp-content/uploads/2014/09/TB-original-e1591582219420-350x250.jpg)
1. A 24-week regimen of bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) resulted in lower mortality, treatment failure, and discontinuation compared ...
1. Compared to a 9-month injectable-containing (control) regimen, both bedaquiline-containing oral regimens had more favourable outcomes, such as negative cultures. ...
1. Rifapentine-moxifloxacin treatment was shown to be non-inferior compared to standard therapy for tuberculosis. 2. Rifapentine without moxifloxacin treatment was ...
1. In this randomized controlled trial, oral lefamulin was noninferior to oral moxifloxacin for treating community-acquired pneumonia, with regards to ...
1. In this randomized controlled trial, oral lefamulin was noninferior to oral moxifloxacin for treating community-acquired pneumonia, with regards to ...
In this section, we highlight the key high-impact studies, updates, and analyses published in medicine during the past week. Four ...
1. The current standard regimen for tuberculosis treatment involves 6 months of antibiotic therapy with isoniazid, rifampin, pyrazinamide, and ethambutol. ...
